LearnSkin

Alternative Medicine Approaches To Eczema

Advances in the Management of Chronic Hand Eczema: What's New?

1 CME Credit1 Lesson
546 Enrolled
Supported by an independent educational grant from LEO Pharma

Course Overview

Preview what you'll learn in this program

1hr
Duration
1
Credit
Jul 2025
Released
Jul 2026
Expires
91% avg
Completion

What You'll Learn

Chronic hand eczema (CHE) is a debilitating condition affecting millions worldwide, often leading to significant physical, emotional, and occupational challenges. This webinar will explore the latest advancements in the diagnosis, treatment, and management of chronic hand eczema, including emerging therapies, innovative treatment approaches, and strategies for improving patient outcomes. Designed for healthcare professionals, this session will provide a comprehensive update on the evolving landscape of CHE care, empowering clinicians to integrate cutting-edge therapies into their practice.

TARGET AUDIENCE

This activity is intended for dermatology clinicians, including residents and fellows, as well as non-clinical staff committed to providing inclusive, equitable care for diverse patient populations.

GOAL & PURPOSE

This activity is designed to appeal to practitioners across disciplines treating patients with dermatologic disease. It will address emerging trends, and practical approaches to chronic hand eczema (CHE) as clinicians assess and manage patients with this condition. Chronic hand eczema is a prevalent, debilitating skin condition affecting up to 10% of the population, with a higher prevalence among individuals in occupations involving frequent handwashing or chemical exposure. There is a great need for best practice sharing and cross-collaboration to support practitioners managing chronic hand eczema and improve patient outcomes.

ACCREDITATION STATEMENT

This virtual activity of Advances in the Management of Chronic Hand Eczema: What's New? is approved for 1 credits of continuing medical education (CME) by Medical Education Resources, Inc.

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and LearnHealth. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT

Medical Education Resources designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSOCIATE CREDIT

Medical Education Resources has been authorized by the American Academy of Physician Associate (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME Credits. Physician Associate should only claim credit commensurate with the extent of their participation.

NURSING CREDIT

Medical Education Resources designates this activity for a maximum of 1 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity. Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hours.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity

Name of FacultyReported Financial Relationship

Sonal Choudhary, MD

Grants/Research Support – Eli-Lilly

Speakers’ Bureau – Sanofi-Regeneron

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content ManagerReported Financial Relationship

Venita Sivamani

LearnHealth Inc. Stockholder

Mer Content Manager

No financial relationships to disclose.

DISCLAIMER

The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of LEO Pharma Inc., MER, and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Contact Information

This activity is jointly provided by MER and LearnHealth. For questions about the CME credit for this activity, contact [email protected] For all other questions, please contact [email protected].

Accreditation Information

Chronic hand eczema (CHE) is a debilitating condition affecting millions worldwide, often leading to significant physical, emotional, and occupational challenges. This webinar will explore the latest advancements in the diagnosis, treatment, and management of chronic hand eczema, including emerging therapies, innovative treatment approaches, and strategies for improving patient outcomes. Designed for healthcare professionals, this session will provide a comprehensive update on the evolving landscape of CHE care, empowering clinicians to integrate cutting-edge therapies into their practice.

Learning Objectives:

  • Identify the pathophysiological mechanisms underlying chronic hand eczema and their implications for targeted therapeutic approaches.
  • Evaluate the efficacy, safety, and clinical applications of emerging therapies, including biologics and Janus kinase (JAK) inhibitors, for managing chronic hand eczema.
  • Develop personalized, evidence-based treatment plans that optimize outcomes and reduce relapses in patients with chronic hand eczema.
  • Incorporate practical strategies for educating patients about chronic hand eczema management to enhance adherence and improve overall quality of life.

✨ Ready to Begin Your Journey? ✨

Enroll now to start the course and unlock all learning materials

Login

Pre-Quiz

Test your knowledge before starting the course

Questions
0
Average Score
78%
Lesson 10hr 52min

Advances in the Management of Chronic Hand Eczema: What's New?

Complete the previous section to unlock this lesson

Post-Quiz

Asess your learning and review your progress

Questions
0
Passing Score
70%
Average Score
91%

Course Evaluation

Complete the post-quiz to unlock the course evaluation

CME Certificate

1 CME Credit

Complete Requirements to Unlock

Finish the post-quiz and course evaluation to receive your certificate

  • Complete all lessons
  • Pass post-quiz (70% or higher)
  • Submit course evaluation

Course Discussion

Join the conversation with fellow learners

LearnSkin Logo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2026.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!